Literature DB >> 22578731

Age and gender related differences in renal cell carcinoma in a European cohort.

Miki N Hew1, Rens Zonneveld, Intan P E D Kümmerlin, Dedan Opondo, Jean J M C H de la Rosette, M Pilar Laguna.   

Abstract

PURPOSE: We evaluated the influence of age on gender related differences in the renal cell carcinoma presentation of patients operated on between 1995 and 2005 in a European country. We also assessed the trend of missing pathological data.
MATERIALS AND METHODS: Data on all patients who underwent radical or partial nephrectomy for renal cell carcinoma during 1995 to 2005 in The Netherlands were retrospectively collected from the prospective PALGA (Pathological Anatomical National Automated Archive) database. Patients were divided into 5 cohorts based on age at surgery, including 40 or less, 41 to 50, 51 to 60, 61 to 70 and greater than 70 years. Variables evaluated were gender differences by age, and tumor size, subtype, stage and Fuhrman grade.
RESULTS: A higher mean age in women was only observed in those older than 70 years (p <0.001). The male-to-female ratio was 2:1 at ages 41 to 60 years and 1.2:1 at greater than 70 years. Compared to men women had smaller tumors at ages 51 to 60 years (p = 0.03), stage pT3 was less common at age 41 years or greater (p = 0.02), and grade 2 was less common at age 61 years or greater (p <0.001). The incidence of tumors with missing data on stage (14.9%), subtype (52.2%) and grade (47.1%) decreased substantially during the study period (p <0.001).
CONCLUSIONS: Older age in women than in men who present to surgery for RCC was only prevalent in those older than 70 years. The male-to-female ratio was almost equal in patients older than 70 years compared to a 2:1 ratio at ages 41 to 60 years. Women presented with fewer pT3 tumors than men at age 41 years or greater. Missing pathological data decreased significantly between 1995 and 2005.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22578731     DOI: 10.1016/j.juro.2012.02.2573

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Gender differences in incidence and outcomes of urothelial and kidney cancer.

Authors:  Ilaria Lucca; Tobias Klatte; Harun Fajkovic; Michela de Martino; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2015-10       Impact factor: 14.432

2.  MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma.

Authors:  Qianqian Shi; Xianlin Xu; Qing Liu; Fengbao Luo; Jian Shi; Xiaozhou He
Journal:  Oncol Lett       Date:  2015-12-31       Impact factor: 2.967

3.  Expression of angiogenic factors is increased in metastasised renal cell carcinomas.

Authors:  Mahmoud Abbas; Johannes Salem; Angelika Stucki-Koch; Mareike Rickmann; Viktor Grünwald; Thomas Herrmann; Danny Jonigk; Hans Kreipe; Kais Hussein
Journal:  Virchows Arch       Date:  2014-01-14       Impact factor: 4.064

4.  Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.

Authors:  Matthias May; Atiqullah Aziz; Richard Zigeuner; Thomas Chromecki; Luca Cindolo; Luigi Schips; Ottavio De Cobelli; Bernardo Rocco; Cosimo De Nunzio; Andrea Tubaro; Ioman Coman; Michael Truss; Orietta Dalpiaz; Bernd Hoschke; Christian Gilfrich; Bogdan Feciche; Anette Stoltze; Fabian Fenske; Hans-Martin Fritsche; Robert S Figenshau; Kerry Madison; Manuel Sánchez-Chapado; Maria Del Carmen Santiago Martin; Luigi Salzano; Giuseppe Lotrecchiano; Steven Joniau; Raphaela Waidelich; Christian Stief; Sabine Brookman-May
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

Review 5.  Is gender becoming relevant in uro-oncological research? A bibliographical analysis.

Authors:  Frank Kunath; Bastian Keck; Simone Bertz; Sabine Brookman-May; Matthias May; Daniel Vergho; Arndt Hartmann; Hubertus Riedmiller; Bernd Wullich; Maximilian Burger
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

6.  Does gender influence morbidity or mortality in the surgical treatment of renal masses?

Authors:  Brian J Minnillo; Andrew Horowitz; Antonio Finelli; Shabbir M H Alibhai; Lee E Ponsky; Robert Abouassaly
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

7.  G-Protein-coupled Estrogen Receptor 1 Agonist G-1 Perturbs Sunitinib Resistance-related Phosphoproteomic Signatures in Renal Cell Carcinoma.

Authors:  Shao-Kuan Chen; Yen-Chieh Wang; Tai-Yuan Lin; Hsin-Jou Wu; Chi-Jung Huang; Wei-Chi Ku
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

8.  Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma.

Authors:  Y Ohno; J Nakashima; Y Nakagami; N Satake; T Gondo; M Ohori; T Hatano; M Tachibana
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

9.  Cellular effects induced by 17-β-estradiol to reduce the survival of renal cell carcinoma cells.

Authors:  Sheng-Tang Wu; Wei-Chi Ku; Chi-Jung Huang; Yen-Chieh Wang; Chih-Ming Lin; Shao-Kuan Chen
Journal:  J Biomed Sci       Date:  2016-09-29       Impact factor: 8.410

Review 10.  Gender-Related Approach to Kidney Cancer Management: Moving Forward.

Authors:  Mariangela Mancini; Marialaura Righetto; Giovannella Baggio
Journal:  Int J Mol Sci       Date:  2020-05-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.